Multicenter, randomised, double-blind, vehicle-controlled study comparing recurrence rate following imiquimod 5% cream or vehicle 3 times per week for 4 weeks prior to ablative therapy in subjects suffering from external ano-genital warts
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Imiquimod (Primary)
- Indications Genital warts
- Focus Therapeutic Use
- Sponsors Meda
- 30 Sep 2008 Actual patient number (128) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Actual completion date (1 Dec 2007) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.